Hypobaric Lateral Spinal Anesthesia Versus General Anesthesia for the Hip Fracture Surgery (RACHYP)

May 19, 2020 updated by: Hospices Civils de Lyon

Hypobaric Lateral Spinal Anesthesia Versus General Anesthesia: Hemodynamic Stability and Short Term Cardiovascular Complications in Elderly Patients Undergoing Hip Fracture Surgery.

Hip fracture is a frequent pathology, involving elderly patients with many co-morbidities ; therefore, post-operative morbidity and mortality is high. It is reported that intra-operative hemodynamics correlate with post-operative complications such as myocardial injury after non-cardiac surgery (MINS) or acute kidney injury (AKI) ; that is why elderly patients undergoing hip fracture surgery should benefit from a better hemodynamic stability.

Low-dose hypobaric lateral spinal anesthesia with a reduced dose of local anesthetic has been shown to have better hemodynamic stability than conventional spinal anesthesia. It has also been reported that general anesthesia and conventional spinal anesthesia in elderly patients undergoing hip fracture surgery have the same hemodynamic effect. However, no published study has compared low-dose hypobaric lateral spinal anesthesia to general anesthesia with regards to hemodynamic effects.

The aim of the present study is to compare the intra-operative hemodynamics of low-dose hypobaric lateral spinal anesthesia with that of general anesthesia in elderly patients undergoing hip fracture surgery.

Study Overview

Study Type

Interventional

Enrollment (Actual)

154

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69003
        • Hôpital Edouard Herriot - Service d'Anesthésie-Réanimation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- Every patient aged 70 years or more who undergoes urgent surgery for a traumatic hip fracture.

Exclusion Criteria:

  • Patients younger than 70 years of age
  • Pathological fractures or multiple trauma
  • Contraindications to spinal anesthesia:
  • allergy to the local anesthetic
  • patients treated by clopidogrel (Plavix®)
  • patients treated by oral anticoagulants: dabigatran (Pradaxa®), rivaroxaban (Xarelto®), or apixaban (Eliquis®).
  • Coagulation disorders: (Prothrombin Time < 50 %, or Partial Thromboplastin Time ratio > 1.5, or platelets < 80 G/L),
  • Local infection of the puncture site
  • hyperthermia (> 38.5°C)
  • agitated patients
  • patients included in another study
  • patients under judicial protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Unilateral spinal anesthesia
In this arm, the patients will have a hypobaric lateral spinal anesthesia. Sedation can be added for the patients comfort.
Unilateral spinal anesthesia with hypobaric local anesthesia allowing a lateralized anesthesia of the fractured limb.
Active Comparator: General anesthesia
In this arm, the patients will have a general anesthesia.
General anesthesia following the latest recommendations for elderly patients (SFAR 2017)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of episode of severe intraoperative hypotension
Time Frame: At Day 0
Occurrence of an episode of severe hypotension defined as a mean arterial pressure (MAP) < 65 mmHg for more than 12 minutes during the operative time.
At Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All-cause mortality
Time Frame: 30 days after surgery
30 days after surgery
Myocardial injury after non cardiac surgery (MINS) occurence
Time Frame: 3 days after surgery
Elevated troponin T level (troponin T > 100 ng/L) in aged patients (over 75 years) and for patients under the age of 75 years old Troponin T> 34 ng/L for men and troponin T > 16 ng / L for women, in a blood test performed in the first 3 days after surgery due to a myocardial ischemia.
3 days after surgery
Acute kidney injury (AKI) occurence
Time Frame: 3 days after surgery
Postoperative AKI is defined as an increase in serum creatinine between preoperative and postoperative values (increase of more than 1.5-fold or more than 0.3mg/dL of the value before surgery.)
3 days after surgery
Hemoglobin rate
Time Frame: 1 day after surgery
Mean decrease between preoperative and postoperative values at 1st and 3rd day after surgery
1 day after surgery
Hemoglobin rate
Time Frame: 3 days after surgery
Mean decrease between preoperative and postoperative values at 1st and 3rd day after surgery
3 days after surgery
Blood loss
Time Frame: At Day 0
Intraoperative blood loss : quantity of blood in the suction container
At Day 0
Quantity of ephedrine used during the intervention
Time Frame: At Day 0
Quantity of ephedrine used during operative time and recovery room
At Day 0
Quantity of noradrenaline used during the intervention
Time Frame: At Day 0
Quantity of noradrenaline used during operative time and recovery room
At Day 0
Number of episodes with a MAP < 65 mmHg for more than 12 minutes during operative time
Time Frame: At Day 0
At Day 0
Total time with MAP < 65 mmHg for more than 12 minutes during operative time
Time Frame: At Day 0
At Day 0
Hospitalisation time
Time Frame: Up to 45 days after surgery
Up to 45 days after surgery
Number of episode of severe hypotension in the recovery room.
Time Frame: At Day 0
Occurrence of an episode of severe hypotension defined as a mean arterial pressure (MAP) < 65 mmHg for more than 12 minutes in the recovery room.
At Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claire DELSUC, MD, PhD, Hospices Civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2018

Primary Completion (Actual)

November 25, 2019

Study Completion (Actual)

November 25, 2019

Study Registration Dates

First Submitted

December 7, 2017

First Submitted That Met QC Criteria

December 11, 2017

First Posted (Actual)

December 14, 2017

Study Record Updates

Last Update Posted (Actual)

May 20, 2020

Last Update Submitted That Met QC Criteria

May 19, 2020

Last Verified

August 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Unilateral spinal anesthesia

3
Subscribe